Please assess the completion status of the following clinical trial:

Trial Title: High-voltage Pulsed Radiofrequency on Gasserian Ganglion to Treat Patients With Primary Trigeminal Neuralgia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of Primary Trigeminal Neuralgia meets the criteria of the International Classification of Headache Disorders.~* 18-75 years old.~* Response to drug treatment poorly or unable to tolerate the side effects of drugs.~* A BNI pain intensity scale score of IV-V.~* Supposed to undergo neurosurgical intervention according to Trigeminal Neuralgia treatment guidelines.~* Agree to participate in this trial and have signed the informed consent.~Exclusion Criteria:~* Abnormal routine blood, liver or kidney functions, abnormal blood biochemistry test, or coagulation disorders.~* Abnormal electrocardiogram or chest X-ray results.~* Severe cardiopulmonary dysfunction.~* Infection at the puncture site.~* History of mental illness, or history of narcotic drug abuse.~* Allergy to local anesthetic drugs or steroids.~* Cannot cooperate with the treatment.~* History of invasive treatments, such as radiofrequency thermocoagulation, chemical ablation, balloon compression surgery, gamma knife treatment, peripheral denervation or microvascular decompression.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- PRF Group (Type: EXPERIMENTAL): This group will undergo 42°C high-voltage pulsed radiofrequency treatment.
- Nerve Block Group (Type: ACTIVE_COMPARATOR): This group will undergo nerve block treatment with steroid and local anesthesia.

Based on this trial design, predict the completion outcome and termination type (if applicable).